Immune Checkpoint Inhibitor-Associated Myositis: A CharacteristicPhenotype with a Poor Outcome Related to Concomitant Myocarditis - Archive ouverte HAL Accéder directement au contenu
Communication Dans Un Congrès Année : 2018

Immune Checkpoint Inhibitor-Associated Myositis: A CharacteristicPhenotype with a Poor Outcome Related to Concomitant Myocarditis

Dates et versions

hal-03831343 , version 1 (26-10-2022)

Identifiants

Citer

Céline Anquetil, Joe-Elie Salem, Benedicte Lebrun-Vignes, Douglas B Johnson, Andrew Mammen, et al.. Immune Checkpoint Inhibitor-Associated Myositis: A CharacteristicPhenotype with a Poor Outcome Related to Concomitant Myocarditis. American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting, ACR/ARHP 2018, Oct 2018, Chicago, United States. pp.1-3584, ⟨10.1002/art.40700⟩. ⟨hal-03831343⟩
21 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More